Journal: Frontiers in oncology
Article Title: CAPRIN2 upregulation by LINC00941 promotes nasopharyngeal carcinoma ferroptosis resistance and metastatic colonization through HMGCR.
doi: 10.3389/fonc.2022.931749
Figure Lengend Snippet: FIGURE 2 CAPRIN2 promotes the ferroptosis resistance, survival, migration and invasion of NPC cells through HMGCR. (A) Overexpression of HMGCR partially reverses the effects of CAPRIN2 on the ferroptosis of ECM-detached 5-8F (left panel) and C666-1 (right panel) cells. The NPC cell lines were treated with erastin (5 mM) for 24 h (B, C) MDA assay (B) and GSH assay (C) results of erastin-treated NPC stable cell lines as indicated. (D) Ectopic expression of HMGCR partially rescues the effects of CAPRIN2 knockdown on ECM-detached NPC cell survival. For (A–C) and (D), the experiments were conducted in triplicate, and the data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01. (E, F) Stable overexpression of HMGCR partially reverses the effects of CAPRIN2 knockdown on 5-8F (E) and C666-1 (F) cell migration and invasion. Representative images of three independent experiments are shown. The data are expressed as the mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet: Primary antibodies against CAPRIN2 (NBP1-88318, Novus), HMGCR (sc-271595, Santa Cruz) and b-actin (66009-1-Ig, Proteintech, Wuhan, China) were commercially obtained. frontiersin.org
Techniques: Migration, Over Expression, Multiple Displacement Amplification, GSH Assay, Stable Transfection, Expressing, Knockdown